EMJ Oncology 10 [Supplement 5] . 2022

Identifying the genomic alterations in non-small cell lung cancer (NSCLC) can allow healthcare professionals to make the most suitable treatment decisions for patients. A common mutation associated with NSCLC involves mesenchymal-epithelial transition (MET). Understanding the MET mutation, and other genomic mutations associated with NSCLC, can help develop more effective personalised treatment.